GOSH appoints new Chief Operating Officer

13 Aug 2020, 9:09 a.m.

John Quinn, Chief Operating Officer at GOSH

John Quinn has been appointed as Great Ormond Street Hospital’s (GOSH) new Chief Operating Officer.

Following a thorough recruitment process, John will be joining the Trust at the end of the calendar year from Moorfields Eye Hospitals NHS Foundation Trust where he is the Chief Operating Officer.

A pharmacist by background, John has also worked at University College London Hospitals NHS Foundation Trust and Buckinghamshire Healthcare NHS Trust and has a wealth of senior and Board-level leadership and management experience.

John Quinn said:

“I have been impressed by the work done at Great Ormond Street Hospital for years. It’s an excellent organisation with a great staff team leading cutting-edge treatment for its patients.

“Coming from Moorfields I’m pleased to be able to bring my experience from one world-class Trust to another as GOSH continues on its journey to improvement to provide the best possible care and experience for patients, their families and staff. I’m really excited to be joining the team and playing my part in this.”

Great Ormond Street Hospital Chief Executive, Matthew Shaw said:

“I am delighted John will be joining our team. He has a broad range of experience across the NHS, including operational leadership in hospitals with a strong research agenda and those running successful commercial services.

“A pharmacist by background, he will also prove invaluable as we transform our medicine management with the building of a Children’s Medicines Centre as part of the next stage of our redevelopment.”

“John also understands the importance of the regional landscape and working with partners across North Central London and beyond to provide better more joined-up care for patients.”

John will join the hospital at the end of the calendar year. Phil Walmsley, who is Interim Chief Operating Officer, will remain in post until then.

GOSH joins partnership to boost early diagnosis and deliver better treatments

GOSH is partnering with LifeArc to set up KidsRare - a new initiative to help deliver more tests and treatments for children living with a rare disease.

Study sheds light on sight-threatening arthritis in children

A team from UCL GOSH and Moorfields Eye Hospital, have discovered B-cells alongside T-cells, play a major role in the development of arthritis‑associated eye disease, JIA‑uveitis.

Orthopaedic Review: End of patient recall report published

Today we have published the summary of our findings.

Lab-grown mini-stomachs could boost understanding of rare diseases

Researchers at Great Ormond Street Hospital (GOSH) and University College London (UCL) have developed the first-ever lab-grown mini-stomach that contains the key components of the full-sized human organ.